Healthcare Triangle, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Operations
| Three Months Ended September 30, · Nine Months Ended September 30, | |||||
|---|---|---|---|---|---|
| Note | 2025 | 2024 | 2025 | 2024 | |
| Net revenue | $3,489 | $2,413 | $10,752 | $9,506 | |
| Cost of revenue (exclusive of depreciation and amortization, shown separately below) | (2,871) | (1,691) | (9,310) | (6,872) | |
| Operating expenses | |||||
| General and administrative | (2,085) | (1,077) | (4,464) | (3,157) | |
| Sales and marketing | (1,022) | (294) | (2,012) | (1,808) | |
| Research and development | (59) | (175) | (257) | (509) | |
| Depreciation and amortization | 3.2 | (63) | (343) | (75) | (1,413) |
| (Allowance)/Reversal for current expected credit loss | 3.1 | 20 | - | 20 | - |
| Total operating expenses | (3,209) | (1,889) | (6,788) | (6,887) | |
| Loss from operations | (2,591) | (1,167) | (5,346) | (4,253) | |
| Other income | 731 | - | 854 | - | |
| Interest expense | (32) | (80) | (467) | (360) | |
| Foreign exchange loss | (14) | - | (14) | - | |
| Loss before income tax | (1,906) | (1,247) | (4,973) | (4,613) | |
| Provision for income tax | - | (2) | - | (8) | |
| Net loss | $(1,906) | $(1,249) | $(4,973) | $(4,621) | |
| Other comprehensive income (OCI) | |||||
| Foreign currency translation gain | 6 | - | 6 | - | |
| Comprehensive loss | $(1,900) | (1,249) | (4,967) | (4,621) | |
| Comprehensive loss attributable to: | |||||
| Stockholders | (1,882) | (4,949) | - | ||
| Noncontrolling interest | (18) | (18) | - | ||
| Net loss per common share - basic and diluted, attributable to: | |||||
| Stockholders | 7 | (0.42) | (54.78) | (2.23) | (224.10) |
| Noncontrolling interest | 7 | (0.00) | - | (0.01) | - |
| Weighted average shares outstanding used in per common share computations: | |||||
| Basic and diluted | 4,443,784 | 22,756 | 2,215,435 | 20,674 | |
The accompanying notes are an integral part of these unaudited consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.